Carregant...
Multiple Mechanisms Underlying the Long Duration of Action of Thienorphine, A Novel Partial Opioid Agonist for the Treatment of Addiction
AIMS: It is considered that a long‐acting therapy would be advantageous in the treatment of addiction. In a search for novel buprenorphine analogues, thienorphine was demonstrated to be an extremely long‐acting orally active partial opioid agonist. This study explored the mechanisms underlying the l...
Guardat en:
| Publicat a: | CNS Neurosci Ther |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492997/ https://ncbi.nlm.nih.gov/pubmed/24330593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12210 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|